Adia Nutrition Inc. Advances Toward United Healthcare Provider Approval for Adia Med Services, Signaling Major Growth Opportunity
United Healthcare
To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/256142_adianutritionimage.jpg
This strategic milestone positions Adia Nutrition to tap into a vastly larger patient population while driving new revenue streams from insurance-backed procedures such as Autologous Hematopoietic Stem Cell Transplantation (AHSCT), Therapeutic Plasma Exchange (TPE), and stem cell therapies that may be covered under the patient's insurance.
"This anticipated provider agreement with United Healthcare is a pivotal step forward in our growth trajectory," said Larry Powalisz, CEO of Adia Nutrition Inc. "It enables Adia Med to deliver its advanced, high-demand therapies to a broader population with insurance support, opening the door for accelerated patient acquisition and scalable expansion."
Once approved, Adia Med will join a select network of providers meeting United Healthcare's rigorous standards for clinical excellence, compliance, and patient care. The company has already begun submitting its first patient's insurance claim through UnitedHealthcare-a strong signal of imminent integration.
United Healthcare's partnership not only validates the clinical quality of Adia Med's offerings but also provides a scalable reimbursement pathway for advanced treatments in the fast-growing regenerative medicine sector.
For investor inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. (OTCQB: ADIA) is a publicly traded company dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.comWebsite: www.adiamed.comWebsite: www.adialabs.comWebsite: www.biolete.comWebsite: www.cementfactory.coTwitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events, or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/256142
Error al recuperar los datos
Inicia sesión para acceder a tu cartera de valores
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
29 minutes ago
- Yahoo
Clean dining: See all 74 South Florida restaurants, food trucks with perfect inspections in June 2025
June marked the return of report-card season at our schools — and that included our South Florida eateries, where 74 restaurants and food trucks earned straight As. In June, 74 'gold-star' restaurants and food trucks made the list of perfect inspections because not one violation — minor, intermediate or high-priority — was red-flagged at the time of the surprise visit from Florida safety and sanitation inspectors. Inspections typically take place at random every six months to a year. In Broward County, 46 eateries earned perfect scores. Meanwhile, in Palm Beach County, 28 passed their inspections without a single incident. The Sun Sentinel has tallied them all up in an easy-to-read format below. NOTE: All restaurants and food trucks listed below have been sorted by city. Those without physical addresses on their Florida Department of Business and Professional Regulation inspection reports have been trimmed from the list. Food and drink concessionaires, professional caterers, event planners — any purveyor that's not a restaurant, food truck, flea market stall or food hall vendor — are also excluded from the roundup. If your city isn't listed, either no restaurants there were inspected that month, or none earned a perfect score.


Medscape
29 minutes ago
- Medscape
IDSA Experts Weigh Potential Vaccine Access Impact
Vaccine access and uptake will be affected by the recent actions of the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP), but the extent remains unclear, according to experts in a press briefing sponsored by the Infectious Diseases Society of America (IDSA). 'I watched with absolute horror as the 17 members of ACIP were summarily fired and replaced with seven members who had limited expertise [in relevant areas],' Andrew T. Pavia, MD, Chief of the Division of Pediatric Infectious Diseases at University of Utah Health, Salt Lake City, Utah, said in the briefing. Vaccines aren't perfect, but one of the fundamental benefits of a functional ACIP is that physicians can watch the deliberations take place and look at the same data that ACIP has reviewed in making recommendations, he said. Without the careful review and debate of evidence, insurers and clinicians alike face uncertainty, he said. Fortunately, ACIP voted to recommend a second monoclonal antibody for prevention of respiratory syncytial virus in infants and recommended that the second product would be added to the Vaccines for Children program, which provides vaccines to approximately half of all children in the United States, Pavia noted. Lack of Vote Adds to Uncertainty Despite much time dedicated to discussion of COVID-19, no vote occurred with recommendations for vaccination for the coming season, said Angela Branche, MD, an associate professor of medicine and infectious diseases specialist and researcher at the University of Rochester, Rochester, New York, in the briefing. Despite evidence presented by CDC experts that young children and pregnant women remain at risk, the lack of a vote leaves clinicians 'operating blind for the coming season as to what to do,' she said. Although ACIP recommended universal flu vaccination, the accompanying restrictions on use of multi-dose vials for flu vaccine may pose access challenges, especially in rural and underserved communities, said Branche. Community clinics in these areas are often pop-ups, and vaccine campaigns tend to be brief, Branche said in the press conference. The use of the now-recommended single-dose flu vaccine vials may be impractical because of the expense of storage and material needed for single-dose injections, she said. Consequently, in terms of vaccine access, communities that are already disadvantaged may be even more so, she emphasized. More Questions as Fall Approaches The reconstituted ACIP also stated intentions to revisit the current recommended childhood vaccine schedule, which could reduce vaccine access for children across the United States, Pavia said. Regarding the current schedule, 'there is no evidence that we are giving too many vaccines to children or too many vaccines close together,' he said in the briefing. If ACIP decided to eliminate any recommended vaccinations from the schedule, the implications are unclear, but insurers might no longer cover them and clinicians might be less inclined to promote them, Pavia said. Currently, vaccine infrastructure of the United States includes nonpartisan, expert review of the science and the clinical recommendations for each vaccine, and many insurers look to ACIP for guidance on coverage, he added.


Bloomberg
32 minutes ago
- Bloomberg
Stock Movers: Datadog, FedEx, Synopsys
On this episode of Stock Movers: - Software company Datadog (DDOG) will be added to the S&P 500 index next week, replacing Juniper Networks Inc. after its recent acquisition by Hewlett Packard Enterprise Co. - FedEx (FDX) is double-upgraded to outperform at BNP Paribas Exane, with the broker saying the stock is 'arguably oversold,' expecting the firm's relative operational outperformance vs. rival UPS to continue. UPS is meanwhile upgraded to neutral from underperform. - Synopsys (SNPS) and Cadence Design both gain 6.1% in premarket trading after the US lifted export license requirements for chip design software sales in China, clearing the way for the companies to resume services in the world's second-biggest economy.